Back to Browse Journals » Vascular Health and Risk Management » Volume 4 » Issue 4

Characterizing blood microparticles: Technical aspects and challenges

Authors Arun S Shet

Published Date September 2008 Volume 2008:4(4) Pages 769—774


Published 4 September 2008

Arun S Shet

Department of Medicine, St. Johns Medical College and Hospital, St. Johns National Academy of Health Sciences, Bangalore, India

Abstract: Although long considered to be cellular debris, microparticles (MPs) are more recently considered refl ective of cellular stimulation, activation, and degeneration/apoptosis. MPs that arise from the cellular components of blood and the endothelial lining of blood vessels are referred to as blood MPs and by general consensus are small (≤1.5 μm), expose the anionic phospholipid (PL) phosphatidylserine (PS) on the outer leaflet of their membrane, and bear surface membrane antigens refl ecting their cellular origin. This brief review summarizes the different approaches used by several groups to study blood MPs. The aim of this article is to review the technical aspects of characterizing the morphological and functional properties of blood MPs with emphasis on the preanalytical and analytical variables involved in these studies.

Keywords: microparticles, flow cytometry, techniques

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Effects of safflower seed extract on arterial stiffness

Katsuya Suzuki, Shigekazu Tsubaki, Masami Fujita, et al

Vascular Health and Risk Management 2010, 6:1007-1014

Published Date: 3 November 2010

Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature

Kathleen Stergiopoulos, Joseph J Brennan, Robin Mathews, John F Setaro, Smadar Kort

Vascular Health and Risk Management 2008, 4:1475-1480

Published Date: 20 November 2008

Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!

Claudia S Vetter-Kauczok, Philipp Ströbel, Eva B Bröcker, Jürgen C Becker

Vascular Health and Risk Management 2008, 4:263-266

Published Date: 6 March 2008

Cholesterol lowering for secondary prevention: What statin dose should we use?

Kiranbir Josan, Finlay A McAlister

Vascular Health and Risk Management 2007, 3:615-627

Published Date: 20 November 2007

Update on stents: Recent studies on the TAXUS® stent system in small vessels

Shuzou Tanimoto, Joost Daemen, Patrick W Serruys

Vascular Health and Risk Management 2007, 3:481-490

Published Date: 4 October 2007

Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients

Ana T Rocha, Edison F Paiva, Arnaldo Lichtenstein, Rodolfo Milani Jr, Cyrillo Cavalheiro-Filho,
Francisco H Maffei

Vascular Health and Risk Management 2007, 3:533-553

Published Date: 4 October 2007

Sirolimus-eluting coronary stents: a review

Alexandre Abizaid

Vascular Health and Risk Management 2007, 3:191-201

Published Date: 23 May 2007

Management of cancer-associated venous thrombosis

Ozlem Er, Leo Zacharski

Vascular Health and Risk Management 2006, 2:351-356

Published Date: 1 March 2006

Metabolic syndrome: the danger signal in atherosclerosis

Patrick Mathieu, Philippe Pibarot, Jean-Pierre Després

Vascular Health and Risk Management 2006, 2:285-302

Published Date: 25 January 2006